Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBCBS Rhode Island Technology Coverage | OpenPayer
    Ask Trek AI about this page
    DraftBlue Cross Blue Shield - Rhode IslandPolicy N/A

    Technology and Miscellaneous Services

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts

    Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Establishes coverage determinations for CPT codes representing new, emerging, and miscellaneous technologies for Medicare Advantage and Commercial Products, including medical necessity principles, prior authorization direction, and use of the coding and coverage grid.

    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyTechnology and Miscellaneous Services
    Policy CodePolicy N/A
    Change TypeNew policy
    Effective DateDec 1, 202614d
    Last ReviewApr 1, 2026
    Next Review DateN/A
    Key ActionFor services requiring prior authorization, consult the related policies identified in the Code and Coverage Grid for the applicable medical criteria.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Product lines addressed
    6Medicare Advantage coverage categories
    7Commercial coverage categories
    Category IIIPrimary CPT code type

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Not covered
    FDA Category A devices

    Coverage Criteria

    General medical necessity

    Items and services must meet all of the following requirements to be considered medically necessary.

    Medical necessity requirements

    • Required characteristics

      • Clinical appropriateness: Consistent with the symptoms or diagnosis of the illness or injury under treatment.
      • Standard of care: Necessary for, and consistent with, generally accepted professional medical standards of care (e.g., not experimental).
      • Not for convenience: Not furnished primarily for the convenience of the patient or of the provider or supplier.
      • Appropriate level of care: Furnished at the most appropriate level of care that can be provided safely and effectively to the patient.

    Medicare Advantage Category B devices

    Medicare Advantage Category B devices may be covered when all applicable requirements are met.

    Category B device coverage

    • Medical reasonableness and necessity: The Category B device is considered medically reasonable and necessary.
    • Other Medicare requirements: All other applicable Medicare coverage requirements are met.

    For Medicare Advantage, FDA Category A investigational devices are considered not medically reasonable and necessary and are therefore not covered. Category A devices are those for which the absolute risk of the device type has not been established and initial safety and effectiveness questions remain unresolved.

    Benefits may vary between groups and contracts. Coverage is governed by the applicable member-specific Benefit Booklet, Evidence of Coverage, or Subscriber Agreement, including provisions addressing health care services that are not covered.

    A treatment or procedure is not medically necessary when reliable evidence shows that the prevailing expert opinion considers additional studies or clinical trials necessary to determine its safety, efficacy, toxicity, maximum tolerated dose, or efficacy compared with a standard treatment or diagnostic method.

    For Commercial Products, a service is not medically necessary when the available evidence is insufficient to determine the effects of the technology on health outcomes.

    For Medicare Advantage, a service may be not covered when the available evidence is insufficient to determine the effects of the technology on health outcomes.

    Provider Actions and Coverage Implications

    Prior Authorization

    Consult related policies before requesting authorization

    For services requiring prior authorization, refer to the Related Policies identified in the Code and Coverage Grid for the appropriate medical criteria. Prior authorization requirements vary by product.

    Prior Authorization

    Check whether the contracted PCP exception applies

    Effective October 1, 2025, a prior authorization request may not be needed for Fully-Funded Commercial Products when the requesting physician is a BCBSRI-contracted primary care provider credentialed in an included specialty. Prior authorization remains required for all other Commercial Products, including Self-Funded products, and for Medicare Advantage Plans.

    • Included specialties are internal medicine, pediatric medicine, family practice, obstetrics and gynecology, doctor of osteopathic medicine, nurse practitioner/primary care provider, and physician assistant.

    Policy Background

    Most services addressed by this policy use CPT Category III codes, which are temporary codes for emerging technologies, services, and procedures. These codes support collection of utilization, clinical efficacy, and outcomes data, but their use does not by itself establish clinical efficacy, safety, or payer coverage. Category III codes may later be converted to Category I codes or archived; archived services generally must be reported with a Category I unlisted code unless another applicable cross-reference exists.

    Key Definitions

    Category III CPT code
    DefinitionTemporary CPT codes for emerging technology, services, and procedures.
    PurposeFacilitate collection of specific data for utilization, clinical efficacy, and outcomes.
    Coverage implicationInclusion in Category III does not establish clinical efficacy, safety, applicability to clinical practice, or payer coverage.
    Category A device
    FDA classificationCategory A (Experimental) device.
    Risk statusThe absolute risk of the device type has not been established.
    Safety and effectiveness
    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyTechnology and Miscellaneous Services
    Policy CodePolicy N/A
    Change TypeNew policy
    Effective DateDec 1, 202614d
    Last ReviewApr 1, 2026
    Next Review DateN/A
    Key ActionFor services requiring prior authorization, consult the related policies identified in the Code and Coverage Grid for the applicable medical criteria.
    SourceLink
    On This Page
    Coverage CriteriaProvider Actions and Coverage ImplicationsPolicy BackgroundKey Definitions
    Billing Rule

    Use the available Category III CPT code

    When a Category III CPT code is available, report it instead of a Category I unlisted code so that specific data can be collected for the emerging service or procedure.

    Documentation Required

    Verify member-specific benefits

    Verify the member’s applicable Benefit Booklet, Evidence of Coverage, Subscriber Agreement, or other governing contract before providing services. Benefits and eligibility are determined by the member’s governing agreement and may vary by group or contract.

    Denial Risk

    Avoid Medicare Advantage evidence and reimbursement denials

    For Medicare Advantage, coverage may be denied when evidence is insufficient to determine the effect of a new or existing unproven technology on health outcomes. Coverage may also be denied when the service is not separately reimbursed or an alternate procedure code must be used.

    Denial Risk

    Check commercial coverage and coding limitations

    For Commercial Products, coverage may be denied when the service is a contract exclusion, is not medically necessary because evidence is insufficient to determine its effects on health outcomes, is not separately reimbursable, or should be reported using an alternate procedure code.

    Denial Risk

    Do not expect coverage for Category A devices

    For Medicare Advantage, FDA Category A investigational devices are considered not medically reasonable and necessary and are not covered.

    Billing Rule

    Obtain advance written agreement before member billing

    If services are determined not medically necessary, or are medically necessary but non-covered benefits, do not charge the member unless the member was informed and agreed in writing in advance to continue treatment at the member’s own expense. Follow the applicable participation agreement.

    Initial questions of safety and effectiveness have not been resolved, and the FDA is unsure whether the device type can be safe and effective.
    Category B device
    FDA classificationCategory B (Non-experimental/investigational) device.
    Primary concernIncremental risk is the primary risk in question.
    Initial safety and effectivenessInitial questions of safety and effectiveness for the device type have been resolved.
    Comparable devicesThe device type may be known to be safe and effective because other manufacturers have obtained FDA premarket approval or clearance for that device type.
    Medically necessary
    Core requirementItems and services must be established as safe and effective.
    Clinical appropriatenessConsistent with the symptoms or diagnosis of the illness or injury under treatment.
    Standard of careNecessary for and consistent with generally accepted professional medical standards of care, and not experimental.
    ConvenienceNot furnished primarily for the convenience of the patient, provider, or supplier.
    Level of careFurnished at the most appropriate level of care that can be provided safely and effectively.